High-grade dysplasia in Barrett's oesophagus: Natural history and review of clinical practice

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 6, 2005, Pages 747-755

  Thomas, T ^a   Richards, C J ^a   De Caestecker, J S ^a   Robinson, R J ^a,b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CLINICAL PRACTICE; COMORBIDITY; DYSPLASIA; ENDOSCOPY; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HISTORY; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGUS; FEMALE; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROTON PUMPS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 16344364529     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02401.x     Document Type: Review

References (26)

1. Cameron AJ, Ott J, Payne WS. The incidence of adenocarcinoma in columnar lined (Barrett's) oesophagus. N Engl J Med 1985; 313: 857-9.
2. Levi F, Randimbison L, Lucchini F, et al. Epidemiology of adenocarcinoma and squamous cell carcinoma of the oesophagus. Eur J Cancer Prev 2001; 10: 91-6.
3. Hammetman W, Tytgat GNJ, Houthoff HJ, et al. Barrett's oesophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-56.
4. Menke-Pluymers MBE, Schoute NW, Mulder AH, et al. Outcome of surgical treatment of adenocarcinoma of Barrett's oesophagus. Gut 1992; 33: 1454-8.
5. Rusch VW, Levine DS, Haggitt R, et al. The management of high-grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer 1994; 74: 1225-9.
6. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's oesophagus. Hum Pathol 1988; 19: 166-78.
7. Rice TW, Falk GW, Achkar F, et al. Surgical management of high-grade dysplasia in Barrett's oesophagus. Am J Gastroenterol 1993; 88: 1832-6.
8. Zaninotto G, Parenti AR, Ruol A, et al. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg 2000; 87: 1102-5.
9. Pera M, Trastek VF, Carpenter HA, et al. Barrett's oesophagus with high-grade dysplasia: an indication for oesophagectomy? Ann Thorac Surg 1992; 54: 199-204.
10. Schnell TG, Sontang SJ, Chejfec G, et al. Long term non-surgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-19.
11. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection in early cancer and high-grade dysplasia in Barrett's oesophagus. Gastroenterology 2000; 118: 670-7.
12. Gossner L, May A, Stolte M, Seitz G, Hahn EG, Ell C. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 1999; 49: 8-12.
13. Van Laethem JL, Cremer M, Peny MO, et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 1998; 43: 747-51.
14. Barr H, Shephard NA, Dix A, et al. Eradication of high-grade dysplasia in columnar lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996; 348: 584-5.
15. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's oesophagus. Gastroenterology 1993; 105: 40-50.
16. University Hospitals of Leicester NHS Trust. Information about University Hospitals of Leicester NHS trust. Available at http://www.uhl-tr.nhs. uk/about_uhl/aboutuhl.html. Last accessed on 3/01/2005.
17. Schlempler RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-5.
18. Dripps RD, Lamont A, Eckenholt JE. Role of anaesthesia in surgical mortality. J Am Med Assoc 1961; 178: 261-6.
19. Attwood SE, Lewis CJ, Caplin S, et al. Argon beam coagulation as therapy for high-grade dysplasia in Barrett's oesophagus. Clin Gastroenterol Hepatol 2003; 1: 258-63.
20. Egger K, Werner M, Meining A, et al. Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut 2003; 52: 18-23.
21. Rudolph RE, Vaughan TL, Storer BE, et al. Effect of segment length on risk of neoplastic progression in patients with Barrett's oesophagus. Ann Intern Med 2000; 132: 612-20.
22. Weston AP, Sharma P, Topalovski M, et al. Long term follow up of Barrett's high-grade dysplasia. Am J Gastroenterol 2000; 95: 1888-93.
23. MacDonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ 2000; 321: 1252-4.
24. Dar MS, Goldblum JR, Rice TW, et al. Can extent of high-grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy? Gut 2003; 52: 486-9.
25. Schnell T, Sontang S, Chejfec G, et al. High grade dysplasia in Barrett's esophagus: a report of experience in 43 patients. Gastroenterology 1989; 96 (Suppl.): A452 (Abstract).
26. Falk GW, Rice TW, Goldblum JR, et al. Seattle biopsy protocol with jumbo biopsy forceps still misses unsuspected cancers in Barrett's oesophagus with high-grade dysplasia. Gastrointest Endosc 1999; 49: 170-6.